Interleukin 2 deficiency induces bone destruction associated with dysregulation of the Rank/Rank Ligand/Osteoprotegerin system.

被引:0
|
作者
Ashcroft, AJ
Lippitt, JM
Perry, MJ
Rollinson, SJ
Croucher, PI
Carding, SR
Morgan, GJ
机构
[1] Univ Leeds, Acad Unit Haematol & Oncol, Leeds LS2 9JT, W Yorkshire, England
[2] Univ Leeds, Sch Biochem & Mol Biol, Leeds LS2 9JT, W Yorkshire, England
[3] Univ Sheffield, Dept Genom Med, Sheffield S10 2TN, S Yorkshire, England
[4] Univ Bristol, Sch Vet, Bristol BS8 1TH, Avon, England
[5] Univ Oxford, Nuffield Dept Orthopaed Surg, Oxford, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
3403
引用
收藏
页码:819A / 819A
页数:1
相关论文
共 50 条
  • [31] IGF-I increases markers of osteoblastic activity and reduces bone resorption via osteoprotegerin and RANK-ligand
    Guerra-Menendez, Lucia
    Sadaba, Maria C.
    Puche, Juan E.
    Lavandera, Jose L.
    de Castro, Luis F.
    de Gortazar, Arancha R.
    Castilla-Cortazar, Inma
    JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
  • [32] Effect of bisphosphonate treatment on serum levels of osteoprotegerin and soluble RANK-ligand in patients with tumor-associated hypercalcemia
    Pohl, G
    Brenner, K
    Hawa, G
    Pecherstorfer, M
    BONE, 2004, 34 : S88 - S89
  • [33] T-cell-mediated colitis and bone destruction in a murine model of autoimmunity are both driven by RANK/RANK LIGAND interactions and modulated by recombinant Fc-OPG
    Ashcroft, AJ
    Cruickshank, SM
    Croucher, PI
    Perry, MJ
    Rollinson, S
    Lippitt, JM
    Child, JA
    Dunstan, CR
    Carding, SR
    Morgan, GJ
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 : 67 - 67
  • [34] Interleukin-33 and RANK-L Interplay in the Alveolar Bone Loss Associated to Periodontitis
    Laperine, Olivier
    Cloitre, Alexandra
    Caillon, Jocelyne
    Huck, Olivier
    Bugueno, Isaac Maximiliano
    Pilet, Paul
    Sourice, Sophie
    Le Tilly, Elodie
    Palmer, Gaby
    Davideau, Jean-Luc
    Geoffroy, Valerie
    Guicheux, Jerome
    Beck-Cormier, Sarah
    Lesclous, Philippe
    PLOS ONE, 2016, 11 (12):
  • [35] Estrogens Modulate RANKL-RANK/Osteoprotegerin Mediated Interleukin-6 Effect on Thyrotoxicosis-related Bone Turnover in Mice
    Mysliwiec, J.
    Zbucki, R.
    Nikolajuk, A.
    Mysliwiec, P.
    Kaminski, K.
    Bondyra, Z.
    Dadan, J.
    Gorska, M.
    Winnicka, M. M.
    HORMONE AND METABOLIC RESEARCH, 2011, 43 (04) : 236 - 240
  • [36] Receptor activator of Nfk-b ligand (RANKL), rank and osteoprotegerin in inflammatory bowel disease: Implication in chronic inflammation and bone loss
    Reenaers, Catherine D.
    Franchimont, Nathalie
    Oury, Cecile
    Lambert, Cecile
    Belaiche, Jacques
    Malaise, Michel
    Delvenne, Philippe
    Louis, Edouard
    GASTROENTEROLOGY, 2006, 130 (04) : A364 - A364
  • [37] CIRCULATING OSTEOPROTEGERIN, SOLUBLE RANK LIGAND, IL-17A AND COMP LEVELS IN RELATION TO BONE MINERAL DENSITY IN PATIENTS WITH SYSTEMIC SCLEROSIS
    Pasalic, Katarina Simic
    Pejnovic, Nada
    Pilipovic, Nada
    Pavlov-Dolijanovic, Slavica
    Damjanov, Nemanja
    Soldatovic, Ivan
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 136 - 137
  • [38] FGF-2 Stimulates RANK Ligand Expression in Paget's Disease of Bone
    Sundaram, K.
    Senn, J.
    Rao, D. S.
    Reddy, S. V.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S128 - S128
  • [39] FGF-2 Stimulation of RANK Ligand Expression in Paget's Disease of Bone
    Sundaram, Kumaran
    Senn, Joseph
    Yuvaraj, Sambandam
    Rao, D. Sudhaker
    Reddy, Sakamuri V.
    MOLECULAR ENDOCRINOLOGY, 2009, 23 (09) : 1445 - 1454
  • [40] CIRCULATING OSTEOPROTEGERIN, SOLUBLE RANK LIGAND, IL17A AND COMP LEVELS IN RELATION TO BONE MINERAL DENSITYIN PATIENTS WITH SYSTEMIC SCLEROSIS
    Pasalic, K. Simic
    Damjanov, N.
    Pejnovic, N.
    Soldatovic, I.
    OSTEOPOROSIS INTERNATIONAL, 2010, 21 : S473 - S474